Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma

Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma

Abstract Background Glioblastoma (GBM), is the most fatal form of brain cancer, with a high tendency for recurrence despite combined treatments including surgery, radiotherapy, and chemotherapy with temozolomide. The C-X-C chemokine receptor 4 (CXCR4) plays an important role in tumour radioresistanc...

Full description

Saved in:
Bibliographic Details
Main Authors: Anthony Waked (Author), Melissa Crabbé (Author), Virginie Neirinckx (Author), Sunay Rodriguez Pérez (Author), Jasmien Wellens (Author), Bernard Rogister (Author), M. Abderrafi Benotmane (Author), Koen Vermeulen (Author)
Format: Book
Published: SpringerOpen, 2024-07-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items